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Background: Cancer patients with primary tumors showing extensive hypoxia and highly elevated interstitial fluid
pressure (IFP) have poor prognosis. The potential of diffusion-weighted magnetic resonance imaging (DW-MRI) in
assessing the hypoxic fraction, IFP, and metastatic propensity of tumors was investigated in this study.
Methods: A-07 and R-18 melanoma xenografts were used as general models of human cancer. DW-MRI was
performed at 1.5 T, and maps of the apparent diffusion coefficient (ADC) were produced with in-house-made
software developed in Matlab. Pimonidazole was used as a hypoxia marker. Tumor cell density and hypoxic fraction
were assessed by quantitative analysis of histological sections. IFP was measured with a Millar catheter. Metastatic
propensity was determined by examining tumor-bearing mice for pulmonary micrometastases post mortem.
Results: ADC decreased with increasing tumor cell density, independent of whether the A-07 and R-18 data were
analyzed separately or together. In the A-07 line, ADC decreased with increasing hypoxic fraction and increasing IFP
and was lower in metastatic than in nonmetastatic tumors, and in the R-18 line, ADC decreased with increasing
hypoxic fraction. There was a strong inverse correlation between ADC and hypoxic fraction as well as between ADC
and IFP across the two tumor lines, primarily because low ADC as well as high hypoxic fraction and high IFP were
associated with high cell density.
Conclusion: Low ADC is a potentially useful biomarker of poor prognosis in cancer, since low ADC is mainly a
consequence of high cell density, and high cell density may lead to increased hypoxia and interstitial hypertension
and, therefore, increased microenvironment-associated metastasis.
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Diffusion-weighted magnetic resonance imaging (DW-
MRI) is an imaging technique that is sensitive to the
Brownian motion of water in tissues [1,2]. Quantitative
information can be obtained, and this information is
usually displayed as maps of a parameter called the ap-
parent diffusion coefficient (ADC). A high ADC indi-
cates relatively free Brownian motion of water, whereas a
low ADC is indicative of restricted motion [2]. The
Brownian motion of water is restricted by organelles, cell
membranes, and extracellular fibers, and consequently,* Correspondence: einar.k.rofstad@rr-research.no
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article, unless otherwise stated.ADC maps can provide information on the microstruc-
ture and composition of tissues. For example, studies of
tumors have shown that high cell density gives rise to
low ADC values, whereas high ADC values are mea-
sured in necrotic tissue [1,2].
DW-MRI has several potentially useful applications in
clinical oncology and is emerging as a powerful tool in
the management of cancer patients. This tool is cur-
rently being used to distinguish malignant from benign
lesions, to differentiate post-therapeutic changes from
residual tumor tissue, to detect recurrent tumors, lymph
node involvement, and distant metastases, and to predict
and monitor response to treatment [3-5]. DW-MRI ap-
pears to be particularly promising for detecting meta-
static disease, both in regional lymph nodes and distanttral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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that ADC may increase rapidly during and after radi-
ation therapy in radiosensitive tumors, an effect that has
been attributed to increased water diffusion due to cell
death, development of edema, and increased microvessel
leakiness [4,5]. However, the prognostic value of the pre-
treatment ADC map and its potential as a biomarker of
outcome of treatment are unclear. On the one hand, low
pretreatment ADC values have been shown to correlate
with several established histological and clinical bio-
markers of poor prognosis [6,7]. On the other hand, sev-
eral studies have suggested that high pretreatment ADC
values are indicative of poor response to treatment, pos-
sibly because of an association between tumor hypoxia
and necrosis [8,9].
Detailed studies of associations between pretreatment
ADC values and the microenvironment of tumors are
needed to evaluate the usefulness of DW-MRI as a tool
for providing biomarkers of tumor aggressiveness and
treatment outcome. Several parameters of the tumor
microenvironment including the level of hypoxia and
interstitial hypertension have been shown to be associ-
ated with metastatic growth, treatment failure, and poor
disease-free and overall survival rates [10-12]. In the
study reported here, human melanoma xenografts were
used to investigate whether DW-MRI may provide infor-
mation on these microenvironmental parameters and
the microenvironment-associated metastatic propensity
of tumors. The A-07 and R-18 melanoma lines were se-
lected for the study because the tumors of these lines




A-07 and R-18 human melanoma xenografts growing in
adult female BALB/c nu/nu mice were used as tumor
models [13]. Tumors were initiated from cells cultured
in RPMI-1640 (25 mmol/L HEPES and L-glutamine)
medium supplemented with 13% bovine calf serum,
250 mg/L penicillin, and 50 mg/L streptomycin. Ap-
proximately 3.5 × 105 cells in 10 μL of Hanks’ balanced
salt solution were inoculated intradermally in the hind
leg. After the cell inoculation, the mice were monitored
daily for tumor growth. Experiments were started when
the tumors had grown to a volume of ~400 mm3. DW-
MRI and IFP measurements were carried out with mice
anesthetized with fentanyl citrate (0.63 mg/kg), fluani-
sone (20 mg/kg), and midazolam (10 mg/kg). Animal
care and experimental procedures were in concordance
with the U.S. Public Health Service Policy on Humane
Care and Use of Laboratory Animals as well as Norwe-
gian legislation and were approved by the Norwegian
National Animal Research Authority.DW-MRI
DW-MRI was carried out with a 1.5-T whole-body clin-
ical scanner (Signa; General Electric, Milwaukee, WI)
and a slotted tube resonator transceiver coil constructed
for mice. The coil was insulated with styrofoam to pre-
vent excessive heat loss from the animals. The body core
temperature of the mice was kept at 37–38°C during im-
aging by using a thermostatically regulated heating pad.
The tumors were positioned in the isocenter of the mag-
net and were imaged axially in a single section through
the tumor center by applying a diffusion-weighted single-
shot fast spin echo sequence with ETL = 84 and TR =
5002 ms. Images were recorded at a spatial resolution
of 0.39 × 0.39 × 2.0 mm3 by using an image matrix of
256 × 256, a field of view of 10 × 10 cm, and 10 excita-
tions. Diffusion sensitization gradients were applied in
six noncollinear directions with the following x, y, and z
physical gradient combinations: [1 0 1], [−1 0 1], [0 1 1],
[0 1 −1], [1 1 0], [−1 1 0]. Five different diffusion-
weightings with diffusion encoding constants of b = 200,
400, 600, 800, and 1000 s/mm2 and corresponding echo
times of TE = 85.0, 95.5, 103.0, 108.9, and 113.9 ms were
used. The diffusion weightings were achieved by using
gradient durations of δ = 11.6, 16.7, 20.8, 24.3, and
27.5 ms, a gradient interval of Δ = 51 ms, and a gradient
strength of GD = 21 mT/m. An image without diffusion
weighting (b = 0) was recorded for each TE value to
compensate for the different TE values associated with
the different b values. The b = 0 images were not in-
cluded in the calculation of ADC. The total scan time
was ~27 min.
ADC maps were produced with in-house-made soft-
ware developed in Matlab. Briefly, the directional diffu-
sion images were averaged on a voxel-by-voxel basis to
non-directional diffusion images. ADC values were cal-
culated for each voxel by fitting the mono-exponential




S b ¼ 0;TEð Þ
 
¼ −b⋅ADC þ c
by using a linear least square fit algorithm. A mono-
exponential model and b values from 200 to 1000 s/mm2
were chosen to avoid confounding effects of perfusion,
as recommended by Padhani et al. [14]. Parametric im-
ages of ADC and the correlation coefficients of the
curve fits were generated with the SigmaPlot software.
It was verified that the mono-exponential model gave
curve fits with correlation coefficients ≥ 0.98 in more
than 95% of the voxels in all tumors. Median ADC, cal-
culated from the ADC values of the individual voxels,
was used as a parameter for the ADC of a tumor.
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Tumor cell density was determined by stereological ana-
lysis of histological sections prepared from tissue fixed in
phosphate-buffered 4% paraformaldehyde. The sections
were stained with hematoxylin to render cell nuclei clearly
visible. The density of cell nuclei was measured by using
the method of Brammer and Jung [15], and the density of
cells was assumed to be equal to the density of nuclei. Five
fields of view, each corresponding to 500 − 600 cells, were
analyzed for each tumor. Further details of the procedure
have been reported elsewhere [16].
Hypoxia
Pimonidazole [1-[(2-hydroxy-3-piperidinyl)-propyl]-2-nitroi-
midazole] was administered intraperitoneally in a dose of
30 mg/kg and used as a marker of tumor hypoxia [17]. The
tumors were fixed in phosphate-buffered 4% paraformal-
dehyde ~4 h after the pimonidazole administration. Histo-
logical sections were immunostained for hypoxia by using a
peroxidase-based indirect staining method [17]. An anti-
pimonidazole rabbit polyclonal antibody (gift from Professor
Raleigh, University of North Carolina) was used as primary
antibody. Diaminobenzidine was used as chromogen,
and hematoxylin was used for counterstaining. Three
cross-sections were examined for each tumor. The area
of the tumor tissue staining positive for pimonidazole
was identified by image analysis [17]. Hypoxic fraction
(HFPim) was calculated as pimonidazole-positive area di-
vided by total tissue area.
Interstitial fluid pressure
IFP was measured in the tumor center with a Millar SPC
320 catheter equipped with a 2 F Mikro-Tip transducer
(Millar Instruments, Houston, TX) [18]. The catheter was
connected to a computer via a Millar TC-510 control
unit and a preamplifier. Data acquisition was carried
out by using the LabVIEW software (National Instru-
ments, Austin, TX).
Pulmonary metastases
Microscopic pulmonary metastases were detected by
histological examination. Resected lungs were fixed in
phosphate-buffered 4% paraformaldehyde and embedded
in paraffin. Histological sections were cut from each lobe
at 100-μm intervals and stained with hematoxylin and
eosin. Groups of five or more tumor cells were scored as
a metastasis.
Experimental design
Three individual experimental series were carried out one
subsequent to the other. In the first series, possible associa-
tions between ADC and tumor cell density were investi-
gated. In the second series, we investigated whether HFPim
and/or IFP may differ between tumors with low and tumorswith high cell densities. Possible associations between ADC
on the one hand and HFPim, IFP, and metastatic propensity
on the other were investigated in the third experimental
series. The mice were first subjected to DW-MRI, then
tumor IFP was measured while the mice were still under
anesthesia, and then the mice were euthanized and the tu-
mors and lungs were resected and prepared for assessment
of HFPim and metastatic status, respectively.
Statistical analysis
Experimental data are presented as mean ± SE unless
otherwise stated. Curves were fitted to data by regression
analysis. Correlations between variables were searched for
by using the Pearson product moment correlation test.
Statistical comparisons of data were carried out by using
the Student’s t test when the data complied with the con-
ditions of normality and equal variance. Under other con-
ditions, comparisons were carried out by non-parametric
analysis using the Mann-Whitney rank sum test. The
Kolmogorov-Smirnov method was used to test for nor-
mality. Probability values (P) and correlation coefficients
(R2) were calculated by using the SigmaStat statistical soft-
ware. A significance criterion of P < 0.05 was used.
Results
Altogether, ADC maps were generated for 35 A-07 and 36
R-18 tumors, IFP and HFPim were measured in 39 A-07
and 38 R-18 tumors, and cell density was determined for
24 A-07 and 22 R-18 tumors. The A-07 tumors showed
a median ADC of 1.0 × 10−3 mm2/s, a median IFP of
12 mmHg, a median HFPim of 3.7%, and a median cell
density of 1.8 × 105 cells/mm3. The corresponding values
for the R-18 tumors were 5.3 × 10−4 mm2/s (ADC),
28 mmHg (IFP), 5.8% (HFPim), and 4.2 × 10
5 cells/mm3
(cell density).
ADC was considerably higher in the A-07 than in the R-
18 tumors. This is exemplified in Figure 1, which shows
the ADC map and the corresponding ADC frequency dis-
tribution of a representative A-07 tumor (Figure 1A) and a
representative R-18 tumor (Figure 1B). The difference in
ADC was most likely a consequence of the lower cell
density in the A-07 than in the R-18 tumors. Figure 1C
shows representative images of the histology of an A-07
(left) and an R-18 (right) tumor, illustrating the difference
in cell density.
Quantitative studies of possible associations between
ADC and cell density were carried out in 10 tumors of
each line. Compared with the R-18 tumors, the A-07 tu-
mors showed higher ADC values (P < 0.00001, Figure 2A)
and lower cell densities (P < 0.00001, Figure 2B). The tu-
mors with cell densities below the median value had
higher ADC values than the tumors with cell densities
above the median value [P = 0.0016, Figure 2C (A-07); P =
0.013, Figure 2D (R-18)]. The inverse relationship between
Figure 1 DW-MRI and histological data showing that A-07 tumors had higher ADC values and lower cell densities than R-18 tumors.
The ADC map and the corresponding ADC frequency distribution of a representative A-07 tumor (A) and a representative R-18 tumor (B) and the
histological appearance of a representative A-07 and a representative R-18 tumor (C).
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single tumor level, both within each melanoma line [P =
0.00086 (A-07); P = 0.0023 (R-18)] and across the two mel-
anoma lines (P < 0.00001).
Fourteen A-07 and 12 R-18 tumors were subjected to
measurement of IFP and subsequent histological examina-
tions to investigate whether HFPim and/or IFP may differ
between tumors with low and tumors with high cell dens-
ities. Compared with the tumors with cell densities below
the median value, the tumors with cell densities above the
median value had both higher HFPim [P = 0.029, Figure 3A
(A-07); P = 0.039, Figure 3B (R-18)] and higher IFP [P =
0.015, Figure 3C (A-07); P = 0.042, Figure 3D (R-18)].
To search for associations between ADC on the one
hand and HFPim, IFP, and metastatic propensity on the
other, 25 A-07 tumors and 26 R-18 tumors were subjected
to DW-MRI and measurement of IFP before the host mice
were euthanized and the tumors and lungs were resected
and prepared for histological examinations. Histological
sections of representative tumors stained for hypoxiaare presented in Figure 4A (A-07) and Figure 4B (R-18).
HFPim differed among the individual tumors from 0 to
12% (A-07) and from 1 to 23% (R-18). ADC decreased
with increasing HFPim, both in the A-07 (P = 0.0080,
Figure 4C) and the R-18 (P = 0.00003, Figure 4D) tu-
mors. IFP differed among the individual tumors from 5
to 23 mmHg (A-07) and from 12 to 35 mmHg (R-18).
ADC decreased significantly with increasing IFP in the
A-07 tumors (P = 0.00015, Figure 4E), but not in the
R-18 tumors (P = 0.10, Figure 4F). Furthermore, by ana-
lyzing the A-07 and R-18 data together, it was shown
that there was an inverse correlation between ADC and
HFPim and between ADC and IFP across the two melan-
oma lines [P = 0.00009 (HFPim); P < 0.00001 (IFP)].
Pulmonary micrometastases were detected in 9 of the
25 mice bearing A-07 tumors, whereas the remaining 16
mice were metastasis-negative. Compared with the tu-
mors of the metastasis-negative mice, the tumors of the
metastasis-positive mice had lower ADC values (P =
0.00017, Figure 5A), higher HFPim (P = 0.017, Figure 5B),
Figure 2 DW-MRI and histological data for A-07 and R-18 melanoma xenografts showing that high ADC was associated with low cell
density. Median ADC (A) and cell density (B) for A-07 and R-18 tumors, median ADC for A-07 tumors with low and high cell densities (cell densities below
and above the median value of 1.8 × 105 cells/mm3) (C), and median ADC for R-18 tumors with low and high cell densities (cell densities below and above
the median value of 4.2 × 105 cells/mm3) (D). Columns and bars represent mean values and standard errors [n = 10 (A and B), n = 5 (C and D)].
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posits were not detected in any of the mice bearing R-18
tumors.
Discussion
The possibility that the pretreatment ADC map may
provide a useful biomarker of the outcome of cancer
has generated a large number of clinical investigations
involving several tumor types [3-8]. Some studies sug-
gest that poor clinical outcome is associated with low
ADC values, whereas high ADC values have been found
to be associated with poor outcome in other studies
[3,5,9,19]. The reasons for these apparently conflicting
observations have not been identified, possibly because
DW-MRI has not been combined with detailed studies
of biological and physiological characteristics of the im-
aged tissue.In the present preclinical study, tumors subjected to
DW-MRI were examined with respect to cell density, frac-
tion of hypoxic tissue, level of interstitial hypertension,
and metastatic status. Tumors with low ADC values were
found to have high cell densities, consistent with the gen-
eral theory that low ADC indicates restricted Brownian
motion of water [1-3]. Furthermore, low ADC values in
tumors were associated with high HFPim, high IFP, and ele-
vated metastatic propensity in A-07 tumors and with high
HFPim in R-18 tumors.
Tumor hypoxia is a result of an imbalance between
the rate of oxygen supply and the rate of oxygen con-
sumption [20]. The rate of oxygen supply is determined
primarily by the vascular architecture and the rate of
blood flow, whereas the rate of oxygen consumption is
determined primarily by the respiratory activity of the
tumor cells and the cell density. In the A-07 and R-18
Figure 3 Hypoxia, IFP, and cell density data for A-07 and R-18 melanoma xenografts showing that high HFPim and high IFP were
associated with high cell density. HFPim for A-07 tumors with low and high cell densities (cell densities below and above the median value of
1.8 × 105 cells/mm3) (A), HFPim for R-18 tumors with low and high cell densities (cell densities below and above the median value of 4.2 × 10
5
cells/mm3) (B), IFP for A-07 tumors with low and high cell densities (C), and IFP for R-18 tumors with low and high cell densities (D). Columns
and bars represent mean values and standard errors (n = 7 for A-07 and n = 6 for R-18).
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HFPim than tumors with low cell densities, suggesting
that the intertumor heterogeneity in fraction of hypoxic
tissue was influenced significantly by the intertumor
heterogeneity in cell density. The inverse correlations
between ADC and HFPim in A-07 and R-18 tumors were
therefore most likely an indirect consequence of the re-
lationship between ADC and cell density.
Interstitial hypertension in tumors is primarily a con-
sequence of high resistance to blood flow, low resistance
to transcapillary fluid flow, decreased interstitial hy-
draulic conductivity, and impaired lymphatic drainage
[21]. In tumors with highly permeable blood vessels like
the A-07 and R-18 tumors, the intertumor heterogeneity
in IFP is mainly a result of intertumor heterogeneity in
resistance to both blood flow and interstitial fluid flow
[22]. High cell density is associated with high resist-
ance to interstitial fluid flow [23], and furthermore, celldivision in rapidly growing tumors with high cell dens-
ities may cause mechanical pressure on vessel walls,
leading to local vessel narrowings and, hence, increased
resistance to blood flow [24]. IFP was higher in tumors
with high cell densities than in tumors with low cell
densities in the A-07 and R-18 lines. The association
between ADC and IFP observed here was therefore
most likely an indirect consequence of the relationship
between ADC and cell density.
There is significant evidence from clinical studies that
poor disease-free and overall rates in cancer are associ-
ated with extensive hypoxia and interstitial hyperten-
sion in the primary tumor [10-12]. Preclinical studies
have revealed that pulmonary and lymph node metas-
tasis is promoted by tumor hypoxia [25,26] and highly
elevated IFP [27,28]. Previous studies have shown that
metastasis is associated with hypoxia and the level of
interstitial hypertension also in A-07 tumors [28,29].
Figure 4 DW-MRI, hypoxia, and IFP data for A-07 and R-18 melanoma xenografts showing that ADC decreased with increasing HFPim
and increasing IFP. Histological sections of a representative A-07 tumor (A) and a representative R-18 tumor (B) stained with anti-pimonidazole
antibody to visualize hypoxic tissue, plots of median ADC versus HFPim for A-07 (C) and R-18 (D) tumors, and plots of median ADC versus IFP for
A-07 (E) and R-18 (F) tumors. Points represent single tumors. Curves were fitted to data by regression analysis.
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which showed that metastatic A-07 tumors had higher
HFPim and higher IFP than their nonmetastatic counter-
parts. The lower ADC in the metastatic than in the non-
metastatic A-07 tumors was most likely an indirect
consequence of higher cell densities in the metastatic
tumors, since both high HFPim and high IFP were asso-
ciated with metastasis, high cell density, and low ADC.
Taken together, our data suggest that low rather than
high ADC values are indicative of tumor aggressiveness
and poor prognosis in cancer. This suggestion is con-
sistent with some clinical investigations, which have
shown that low ADC values in untreated tumors may
be associated with several established biomarkers of
poor prognosis in breast [6], prostate [7], and lung
cancer [30]. Recent clinical studies have also provided
significant evidence that low ADC values may be acharacteristic feature of primary tumors that are likely
to metastasize [31]. Moreover, aggressive tumors have
been demonstrated to have lower ADC values than in-
dolent tumors in patients with localized prostate cancer
[32], and the ADC of the primary tumor has been found
to be lower in patients with metastatic disease than in
patients without detectable metastases in high-grade
urothelial carcinoma of the bladder [33].
In contrast, some preclinical and clinical studies have
suggested that poor response to treatment is associated
with high pretreatment ADC values [8,9]. High ADC
values may be associated with treatment resistance if
the treatment resistance is caused by hypoxia and the
tumors show significant hypoxia-associated necrosis.
Proper evaluation of the prognostic and predictive po-
tential of DW-MRI may require that voxels in necrotic
tumor regions are excluded from ADC maps, since ADC
Figure 5 DW-MRI, hypoxia, IFP, and metastasis data for A-07 melanoma xenografts showing that metastatic tumors had lower ADC,
higher HFPim, and higher IFP than nonmetastatic tumors. Median ADC (A), HFPim (B), and IFP (C) for metastatic and nonmetastatic tumors.
Points represent single tumors. Horizontal bars indicate mean values.
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vated ADC values seen in necrotic tissue. Necrotic tumor
regions may be identified by combining DW-MRI with
contrast-enhanced MRI [34]. It is important to note that
A-07 and R-18 tumors in general do not develop necrotic
regions until they reach a volume of 700 − 800 mm3 [13],
and necrosis was not seen in any of the histological sec-
tions examined in the present work.
In preclinical studies, each tumor line represents a
single patient, whereas individual tumors of the same
line represent copies of the same tumor. These tumor
copies have the same genetic background, but may show
substantially different physiological microenvironments
owing to the stochastic nature of tumor angiogenesis.
By studying many tumors of the same xenograft line,
associations between MRI-derived parameters and pa-
rameters of the tumor microenvironment can be re-
vealed. However, these MRI-derived parameters cannot
be expected to be prognostic for the clinical outcome
of cancer unless they show significant correlations with
microenvironmental parameters across tumor lines. In-
terestingly, ADC showed significant inverse correla-
tions with cell density, HFPim, and IFP across the two
melanoma lines included in this study, consistent with
the hypothesis that tumor ADC may be an important
prognostic factor in cancer.
The hypothesis that low ADC may indicate poor prog-
nosis is also supported by the observation that low ADC
was associated with pulmonary metastasis in A-07 tumors.
On the other hand, the observation that R-18 tumors
showed lower ADC values than the A-07 tumors and didnot give rise to pulmonary metastases is apparently in-
consistent with this hypothesis. Previous studies have re-
vealed that the A-07 and R-18 xenograft lines show
organ-specific metastatic patterns (i.e., A-07 tumors
metastasize primarily to the lungs, whereas R-18 tumors
preferentially develop lymph node metastases) [13]. The
incidence of lymph node metastases was not scored in
the present investigation. However, previous investiga-
tions have revealed that the development of lymph node
metastases in R-18 tumors is associated with poor blood
supply and high fractions of hypoxic tissue [35] and,
furthermore, that hypoxia promotes lymph node me-
tastasis in R-18 tumors primarily by up-regulating the
expression of the urokinase-type plasminogen activator
receptor [36].Conclusions
This study confirmed that low ADC is associated with
high cell density in tumors and revealed that tumors
with high cell densities may have high hypoxic frac-
tions, high IFP, and elevated metastatic propensity.
Low ADC was found to be associated with high HFPim,
high IFP, and metastasis, primarily because these pa-
rameters were all associated with high tumor cell dens-
ity. Taken together, our observations suggest that low
pretreatment ADC values may be associated with a
hostile microenvironment in tumors. Consequently,
the possibility that DW-MRI may provide biomarkers
of microenvironment-associated tumor aggressiveness
and treatment resistance merits clinical investigations.
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